Remed Co.Ltd (302550) — Capital Reinvestment Ratio
Latest as of March 2026:
0.37x
Remed Co.Ltd (302550) has a Capital Reinvestment Ratio of 0.37x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩238.69 Million) in capital expenditures (₩88.33 Million). See 302550 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.37x
Capex / Operating Cash Flow
Operating Cash Flow
₩238.69 Million
KRW
Capital Expenditures
₩88.33 Million
KRW
Data as of
Mar 2026
Most recent filing
Remed Co.Ltd Capital Reinvestment Ratio (2017–2025)
This chart tracks Remed Co.Ltd's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for Remed Co.Ltd (2017–2025)
Year-by-year Capital Reinvestment Ratio for Remed Co.Ltd from 2017 to 2025. For live market cap and broader valuation context, see 302550 company net worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.36x | ₩2.40 Billion | ₩868.76 Million | ▼ -25.9% |
| 2024 | 0.49x | ₩1.24 Billion | ₩608.80 Million | ▲ +91.5% |
| 2023 | 0.26x | ₩3.50 Billion | ₩893.97 Million | ▼ -72.1% |
| 2022 | 0.92x | ₩5.21 Billion | ₩4.77 Billion | ▲ +248.9% |
| 2020 | 0.26x | ₩2.59 Billion | ₩679.62 Million | ▼ -57.9% |
| 2019 | 0.62x | ₩3.22 Billion | ₩2.01 Billion | ▼ -94.6% |
| 2017 | 11.52x | ₩66.75 Million | ₩768.89 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow